SugarMD
SugarMD Benfotiamine 300 MG – 60 Capsules
SugarMD Benfotiamine 300 MG – 60 Capsules
Couldn't load pickup availability
Protect your body against oxidative stress¹ and support your wellness journey with SugarMD Benfotiamine, a premium fat-soluble form of Vitamin B1.
-
Potent 300 mg of Fat-Soluble B1: Each capsule delivers 300 mg of Benfotiamine, an advanced, highly bioavailable form of Vitamin B1 that is more easily absorbed and retained by the body.
-
Comprehensive Cellular & Nerve Support: Formulated to help protect against oxidative stress¹, promote cellular integrity, and support healthy nerve function².
-
Supports Metabolic Balance: Aids in maintaining metabolic balance, making it an excellent supplement for comprehensive wellness³ support.
-
Robust Antioxidant Protection: Designed to provide powerful antioxidant defense as part of a proactive health regimen.
-
Commitment to Purity: Every batch is "Lab Tested for Purity", ensuring it is free from contaminants like pesticides and heavy metals. Made with clean, natural ingredients you can trust.
Important Disclaimer:
-
This product is a dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease.
-
These statements have not been evaluated by the Food and Drug Administration (FDA).
-
Consult your healthcare provider before use, especially if you are pregnant, nursing, taking medications, or have a medical condition. Not intended for individuals under 18.
-
Gallery images are for reference only. Actual product details may vary.
References:
- Tamayo, Carmen, and Suzanne Diamond. “Review of Clinical Trials Evaluating Safety and Efficacy of Milk Thistle (Silybum Marianum [L.] Gaertn.).” Integrative Cancer Therapies 6, no. 2 (2007): 146-157.
-
Fraser, David A., Lien M. Diep, Inger Anette Hovden, Kristian B. Nilsen, Kari Anne Sveen, Ingebjørg Seljeflot, and Kristian F. Hanssen. "The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, Double-blind, Randomized, Placebo-controlled Trial." Diabetes Care 35, no. 5 (2012): 1095–1097. https://doi.org/10.2337/dc11-1895.
-
Sambon, Margaux, Pierre Wins, and Lucien Bettendorff. 2021. "Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine" International Journal of Molecular Sciences 22, no. 11: 5418. https://doi.org/10.3390/ijms22115418
Share
